Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials
RM Green, KL Bicker - International journal of antimicrobial agents, 2020 - Elsevier
Introduction Antimicrobial peptides are proving to be promising lead compounds for
therapeutics. The major disadvantage of antimicrobial peptides is their proteolytic instability …
therapeutics. The major disadvantage of antimicrobial peptides is their proteolytic instability …
Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials.
RM Green, KL Bicker - 2020 - cabidigitallibrary.org
Introduction: Antimicrobial peptides are proving to be promising lead compounds for
therapeutics. The major disadvantage of antimicrobial peptides is their proteolytic instability …
therapeutics. The major disadvantage of antimicrobial peptides is their proteolytic instability …
Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials
RM Green, KL Bicker - International Journal of Antimicrobial Agents, 2020 - hero.epa.gov
Antimicrobial peptides are proving to be promising lead compounds for therapeutics. The
major disadvantage of antimicrobial peptides is their proteolytic instability in the body, with …
major disadvantage of antimicrobial peptides is their proteolytic instability in the body, with …
Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials
RM Green, KL Bicker - International journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Antimicrobial peptides are proving to be promising lead compounds for
therapeutics. The major disadvantage of antimicrobial peptides is their proteolytic instability …
therapeutics. The major disadvantage of antimicrobial peptides is their proteolytic instability …
Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials.
RM Green, KL Bicker - International Journal of Antimicrobial Agents, 2020 - europepmc.org
Methods This study evaluated peptoid derivatives of ultra-short lipophilic antimicrobial
peptides, comparing their potency side-by-side with the most prevalent multidrug-resistant …
peptides, comparing their potency side-by-side with the most prevalent multidrug-resistant …